The Soft Tissue Repair Market World Leading Key Players Revenue, Share, Analysis And Estimation Till 2023

Market Highlights

The Global Soft Tissue Repair Market is expected to grow at an approximate CAGR of 6.2% during the forecast period, 2018–2023.

The rising cases of sports-related injuries and technological advancements are some of the key factors driving the soft tissue repair market. For instance, in 2016, Colorado Therapeutics received FDA approval for its xenograft implant. The xenograft implant is designed for the surgical repair of damaged or ruptured membranes.

Various other factors such as increasing awareness about orthopedic disorders and other related conditions, improvement in reimbursement policies, untapped emerging markets, and increasing healthcare expenditure are also expected to propel the growth of the market.

However, the high cost of advanced equipment and a shortage of physicians in emerging markets can hamper market growth over the forecast period.

Regional Analysis

The Americas dominated the global market for soft tissue repair owing to the increasing healthcare expenditure presence of major market players and rising geriatric population within the region. As per the data suggested by the United Census Bureau, by 2060, the US is projected to grow by 79 million people, from about 326 million today to 404 million. The population is projected to cross the 400-million threshold in 2058.

In 2017, it was estimated that Europe stood second in the global soft tissue repair market. Robust research and development (R&D) sector along with the availability of funding opportunities in research and innovation will support the market growth.

Asia-Pacific (APAC) is expected to represent the phenomenal market growth throughout the forecast period due to increasing demand for medical technology, growing health awareness, and growing aging population coupled with the rising prevalence of orthopedic diseases in India, Japan, and Australia. For instance, according to the United Nations Economic and Social Commission for Asia and the Pacific (ESCAP), in 2016, around 12.4% of the population in the region was 60 years or older and is projected to reach to more than 1.3 billion by 2050.

On the other hand, the Middle East and Africa held the least share in the global soft tissue repair market due to the low economic development, especially within the African region.

Segmentation

The global soft tissue repair market is segmented based on product, application, end user, and region.

the global market for soft tissue repair, by product, is segmented into fixation products, tissue patch/match, laparoscopic instrument, and others. The fixation products segment is further classified as a suture, suture anchors, and interference screw. The tissue patch/match segment is further classified as biological, and synthetic. The biological segment includes allograft and xenograft.

Based on application, the market is segmented into orthopedic surgery, skin repair, hernia repair, vaginal sling repair, dental reconstruction, cardiovascular surgery, breast reconstruction, and others.

Based on end user, the market is segmented into hospitals, clinics, research & academic institutes, and others.

Key Players

Some of the key players in the global soft tissue repair market are Stryker Corporation, C.R. Bard, Inc., Arthrex, Inc., Integra LifeScience Corporation, Depuy Synthes, Smith & Nephew plc, Allergan Plc., Athersys, Inc., CryoLife, Inc., Medtronic Plc., Organogenesis Inc., Zimmer Biomet Holdings, Inc., Lifenet Health, Inc., American Medical Systems Inc., US Stem Cell, Inc., Wright Medical Group, Inc., Isto Biologics, and others.

Browse More Report Details @ https://www.marketresearchfuture.com/reports/soft-tissue-repair-market-7810  

Digital 3D Printing Market Overview By Trends, Industry Top Manufactures, Size, Industry Growth Analysis & Forecast Till 2025

Digital 3D Printing Market size is expected to register a CAGR of 20.54% to reach USD 5,214.8 Million by 2025. 3D Printing is a process in which physical objects are created by depositing materials in layers based on a digital model. The creation of a 3D printed object is achieved using additive processes. In an additive process, an object is created by laying down successive layers of materials until the object is created. 3D Printing enables to produce complex shapes using less material than traditional manufacturing methods. Each 3D Printing process requires software, hardware, and materials to work together.

Market Dynamics

Increasing applications of Digital 3D Printing in healthcare industry is expected to boost market growth. 3D Printing techniques have empowered medical practitioners, manufacturers of medical devices, as well as researchers due to their use in dental & orthodontic treatments, orthopedic implants, tissue engineering, and drug development. As a result, the increasing benefits of the mentioned applications would boost digital 3d printing market growth. 3D Printing technique is useful to speed up procedures and helps to minimize the trauma faced by patients due to conventional treatment options. Technological advancements in digital 3D Printing, rising public-private funding for 3D Printing activities are the major drivers that contribute to the growth of the digital 3D Printing market.

Segmentation

Global Digital 3D Printing Market analysis is segmented based on Component, Material, Technology, Application and End User.

The market, based on component, has been categorized as system/device and software/services. System/Device held 867.53 market value in 2018

Global digital 3D Printing market, based on material, has been segregated into polymers, metal & alloy, ceramics, and others.

Global digital 3D Printing market trends based on technology, has been segregated into stereolithography, deposition modeling, laser sintering, jetting technology, electron beam melting, and others.

Global digital 3D Printing market based on application has been categorized into dental, prosthetics, orthopedics, medical components, tissue engineering, hearing aids, drug screening, and others.

Global digital 3D Printing market, based on end user, has been segregated into hospitals & surgical centers, dental clinics & laboratories (offices), pharmaceutical & biotechnology companies, and others.

Regional Analysis

Global Digital 3D Printing Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas led the market and accounted for the largest share in 2018, owing to the existence of medical device companies and the rising prevalence of diseases along with increased adoption of treatment by patients. In North America, the US held the largest of the market share in 2018 owing to the presence of major market players, developed healthcare infrastructure, high awareness, and availability of advanced treatment options. For instance, in November 2015, a group of medical researchers from North Carolina’s Wake Forest University developed a method to print the 3D form of custom medications in the configuration of pills. As a result, increasing applications of 3D Printing is expected to drive the market growth.

Europe accounts for the second-largest share in the global digital 3D Printing market owing to the presence of favorable government initiatives & laws and target population base, rising prevalence of lifestyle-associated conditions, and the presence of developed economies such as Germany, the UK, and France. Since the ban on animal testing for cosmetics in 2013, the wellness industry had been a significant supporter of 3D Printing in Europe.

Asia-Pacific is estimated to be the fastest-growing market during the forecast period due to the increasing per capita health spending, growing older population base, rising incidence of accidents, and developing the healthcare sector in China, Japan, India, and Australia.

The Middle East & Africa digital 3D Printing market is segmented into two major regions, namely the Middle East and Africa. In this region, the Middle East is anticipated to dominate owing to the presence of countries such as Egypt, Saudi Arabia, and others. The Middle East and Africa has less economic developments and extremely low-income due to which the region accounts for the least market share but is expected to grow with the increasing cases of chronic diseases and demand for better treatments in countries.

Key Players

The Prominent Players in the Global Digital 3D Printing Market are Stratasys Ltd (US), 3D Systems, Inc. (US), Carbon, Inc. (US), EnvisionTEC (US), Formlabs (US), ExOne (US), Materialise (Europe), General Electric (US), Micron Dental (US), Renishaw PLC (UK).

Some of the key strategies followed by players operating in the Global Digital 3D Printing Market were acquisitions, expansions, product launches, partnerships, mergers, collaborations, alliances, and product approvals.

• In June 2019, Materialise received the FDA clearance for the cardiovascular planning software suite. Thus, the suite has helped clinicians to produce patient-specific 3D models for more than 20 years.

• In November 2019, ExOne introduced the X1 160PRO metal 3D printer for high-volume production of quality parts.

• In February 2019, EnvisionTEC and AvaDent digital dental solutions announced a new partnership. This partnership offered a complete digital workflow solution for digital dentures, from impressions and digital design to try-in and final restoration.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/digital-3d-printing-market-8680

Hyperspectral Imaging System Industry Growth, Trends And Forecast Till 2025 By Marketresearchfuture.Com

Market Highlights

According to MRFR analysis, Global Hyperspectral Imaging System Market is expected to register a CAGR of 17.4% during the forecast period of 2019 to 2025 and held a value of USD 10,700 Million in 2018.

Hyperspectral imaging system has wide applications in areas such as art conservation, vegetation, water resource control, archaeology, food quality, forensic medicine, crime scene detection, and forensic medicine. HSI technology is mainly used by the defense sector, government agencies, and non-military application sectors such as agriculture and mineral.

The growth of the global hyperspectral imaging system market is boosted by various factors such as the growing industrial applications of hyperspectral imaging,  Technological advancements in electronics industry, such as sensor design, high spectral resolution, high spatial resolution, compact and lightweight devices, growing prevalence of cancer, and increasing awareness of innovative diagnostics methods.

Additionally, the introduction of innovative products in the market is expected to drive the growth of the market during the forecast period. For instance, In January 2020, Specim, Spectral Imaging Ltd. (Finland), launched Specim’s new AFX10, a compact hyperspectral camera for airborne use. Specim’s new AFX10 is easy to use and can be used to check water quality, estimating the fertilizing need in agriculture, identifying vegetation species, or studying wildlife population

However, the high cost associated with the use of hyperspectral imaging and scarcity of qualified professionals is likely to hamper the growth of the market during the forecast period.

Several market players currently dominate the global hyperspectral imaging system market. The key players are engaged in product launches and strategic collaborations to strengthen their market positions.

Regional Analysis

The Market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas held the maximum share in the year 2018, owing to the presence of established key players in countries such as the US and Canada. The hyperspectral imaging system market in the Americas has further been categorized into North America and Latin America, with the North American market further divided into the US and Canada. The European hyperspectral imaging system market has been categorized as Western Europe and Eastern Europe. The Western European market has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The hyperspectral imaging system market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The hyperspectral imaging system market in this region is anticipated to be the fastest growing during the assessment period due to the rising mining activities, and blooming healthcare, agriculture, and biotechnology sector in the region. The hyperspectral imaging system market in the Middle East & Africa has been divided into the Middle East and Africa.

Segmentation

The Global Hyperspectral Imaging System Market has been segmented based on Product, Technology, and Application.

The market, based on product, has been divided into visible/near-infrared (VNIR), short-wave infrared (SWIR), mid-wave infrared (MWIR), long-wave infrared (LWIR). The Visible/Near-Infrared (VNIR) systems segment is likely to be the largest due to the high adoption of visible/near-infrared (VNIR) systems in various industries. The mid-wave infrared (MWIR) segment is predicted to be the fastest-growing due to increasing awareness about the rising adoption of MWIR systems in detecting volcanic vents, industrial gas leaks, or biomass burning events.

The global hyperspectral imaging system market has been segmented, based on the technology, into push broom, snapshot, and others. The push broom segment is anticipated to be the largest segment during the forecast period due to the rising popularity of these devices owing to the simplified illumination requirements, minimized illumination exposure, high spectral resolution, and heat load, and the shorter capturing time.

The applications segment of the global hyperspectral imaging system market surveillance, remote sensing, machine vision/optical, and medical diagnostics. The surveillance segment is likely to hold the maximum share during the forecast period due to the rising adoption of innovative technologies in the defense sector.

Key Players

Some of the Key Players in the Global Hyperspectral Imaging System Market are Headwall Photonics, Inc. (the US), Specim, Spectral Imaging Ltd. (Finland), Norsk Elektro Optikk as (NEO) (Norway), Resonon, Inc. (the US), Corning Incorporated(US), Telops (Canada), Applied Spectral Imaging(US), Bayspec, Inc.(the US), Surface Optics Corporation (US), Chemimage Corporation (US), Cubert GmbH (Germany), Raytheon (US), Galileo Group, Inc.(the US), Hypermed Imaging, Inc.(the US), Inno-Spec (Germany), Camlin Group Ltd. (UK), IMEC (Belgium), XIMEA GmbH (Germany), among others.

Browse More Report Details @ https://www.marketresearchfuture.com/reports/hyperspectral-imaging-system-market-8741

4D Printing in Healthcare Market 2019 – Leading Manufactures, Regions, Drivers, Analysis And Forecasts Till 2025

Market Overview

Global 4D Printing in Healthcare Market is expected to register a CAGR of 29.4% during the forecast period from 2019 to 2025 and expected to reach USD 30.4 Million by 2025.

In the past decade, there has been increasing use of 3D printing in the field of healthcare. The introduction of 4D printing and its shape-changing material property in the field of dentistry, implants, and prosthetics, among others will further enhance the 3D products used for these applications. The shape-changing property of the material used for 4D printing has been one of the major factors influencing the growth of the market.

Moreover, factors such as increasing research and development, rising investment by chemical companies. These chemical companies are keen on grabbing the opportunity for the development of smart materials in 4D printing, which in turn is directly enhancing the growth of the market.

Factors such as stringent regulatory policies for the approval of 4D printing medical devices market trends and limited skilled professionals have been major challenges for 4D printing in the healthcare market.  

Market Drivers

• Increasing application of 4D printing in healthcare verticals such as dentistry, implants, and prosthetics.
• The dental industry is one of the major applications of 4D printing. Clear aligners have been the most manufactured products via 3D printing in the dental industry.
• Align technology, the leader in global clear aligners market, accounts for about 80% of the market. The company uses 3D Systems to produce over 1.6 million custom aligners per week.
• Clear aligners can further be enhanced using 4D printing, as these products require shape altering properties according to the changing structure of the teeth on a weekly basis.
• 4D printers are also used to manufacture various dental implants, including dental implants, dentures, crowns, & bridges, among others.
• Increasing prevalence of dental diseases is further influencing the growth of the market. According to the MRFR research study in 2018, it was estimated that oral diseases affected more than 3.7 billion individuals that are around half of the world’s population.

• Rising research and development
• A research team from the US in March 2019, invented a new bio-ink that allows to print catalytically active live cells into several self-sustaining 3D geometries. These properties include tunable cell densities, fine filament thickness, and high catalytic productivity.

• Growing investment by chemical companies
• Various companies such as BASF Venture Capital GmbH and Evonik Venture Capital have invested in Chinese 3D printing companies

Market Challenges

• Stringent regulatory policies for the approval of 4D printing medical devices
• Limited skilled professionals

Segmentation

By Component

• Software & Services: Software and services accounted for the major market share in 2018. 3D printers have already been installed in numerous healthcare facilities across the globe. However, these machines would require updated software and also various services for the manufacturing of 4D products.

• Smart Material: Smart Material segment is expected to grow at the fastest growth rate due to continuous advancements for the materials in 4D printing. Investment by chemical companies for the development of smart material is further influencing the market growth.

By Technology

• Fused Deposition Modeling: Accounted for the largest market share due to its wide choice of raw materials and cost-effective process

• Direct Inkjet Cure: Expected to grow at the fastest growth rate majorly due to its dimensional accuracy, multi-material, and full-color printing properties

By Application

• Dental: accounted for the largest market share owing to the use of 4D printing for manufacturing of wide dental products including clear aligners, implants, and dentures among others

• Prosthetics: Expected to grow at the fastest growth rate due to increasing number of prosthetic procedures, accidental injuries, and sports injuries among others

By End-User

• Hospitals & Surgical Centers: Accounted for the leading market share owing to the increasing number of hospital & surgical centers. According to a study published by the American Hospital Association, there were 5,534 registered hospitals in the US in 2017.

• Dental Clinics & Laboratories (Offices): Use of 4D printing in dental clinics & laboratories, brings less complexity to existing procedures. Dental laboratories use 4D printing technologies that allow them to increase competitiveness and production, thus driving the growth of this segment.

By Region

• Americas: The Americas spearheaded the market in 2018 and is likely to continue to command during the assessment period. This is attributed to the existence of a large number of medical device companies, increasing research and development, and the presence of a large number of noticeable players engaged in manufacturing of 4D printing devices and software

• Europe: Reported for the second-largest share owing to increasing utilization of 3D & 4D printing in the field of healthcare. According to a study conducted in 2018, it was found that 65% of healthcare providers are implementing new printing technologies for medical products using custom made materials

• Asia-Pacific: The highest growth rate is attributed to the growing investment by government bodies and private & public companies. For instance, in November 2018, BASF Venture Capital GmbH invested in Chinese 3D printing company Prismlab.

Key Development

• In January 2019, Dentsply Sirona and Carbon announced a strategic collaboration to revolutionize digital denture materials. This strategic collaboration was announced to deliver denture materials for carbon digital 3D printing production solutions.

Key Players

• Stratasys Ltd (US)
• 3D Systems, Inc (US)
• EnvisionTEC (Germany)
• Poietis
• (France) 
• Organovo Holdings Inc. (US)
• Materialise NV (Belgium)
• Dassault Systèmes (France)  

Browse More Report Details @   https://www.marketresearchfuture.com/reports/4d-printing-healthcare-market-8630 

Meningococcal Vaccines Market Professional Overview 2019-2025 With Major Vendors Size, Shares And Worldwide Demand

Market Forecast

Meningococcal Vaccines Market has a demand for USD 172 Million doses in 2019. Further, the global estimated supply in 2019 is expected to be 203 Million doses.

Market Synopsis

Meningococcal meningitis is a bacterial infection caused by Neisseria meningitides. Disease incidence is high in West and Central Africa, where historically, serogroup A has been the most important cause of disease. More recently, meningitis outbreaks have gradually been associated with serogroup C, and to a lesser extent, serogroup W.

The meningococcal vaccines market is complex and diverse, with regional variations in serogroup distribution with substantial use outside routine immunization. The vaccine has approximately 29 marketed products targeting various combinations of the six serogroups (A, B, C, W, X, Y).

Market Influencer

Without an increase in production, the existing supply of conjugate MenACWY will be inadequate to meet the demand generated by the rising incidence of serogroups C and W, and the low availability of polysaccharide vaccines. Further, several multivalent, conjugate vaccines by Chinese and Indian manufacturers are in the pipeline, and, if prequalified they will be registered for use in many geographies. Moreover, if they are made available at acceptable prices it could increase global demand in Meningococcal Vaccines Market.

Market Drivers

• Rise in prevalence of the meningococcal disease
• According to a document published by the U.S. Department of Health & Human Services, in 2017, there were approximately 350 cases of meningococcal disease reported. The disease has an incidence rate of 0.11 cases per 100,000 people in the United States. Any population group can be affected by the disease, with maximum prevalence in children younger than one-year-old and a second peak in adolescence. Adolescents and young adults, ranging from 16 to 23 years old, have the highest rates of meningococcal disease.
• Further, increasing incidence of meningococcal disease in West and Central Africa regions is expected to drive the demand in the African region
• Booming mortality of the meningococcal disease is leading to increasing demand for the vaccines
• Approximately 10 to 15 in 100 people affected with meningococcal disease will face mortality. Further, up to 1 in 5 survivors will have long-term disabilities, such as loss of limb, deafness, and damage to the nervous system brain among others
• Escalating positive results with the vaccines to boost the demand in the market
• Growing research and development activities by prominent players in the industry

Market Restraints

• Withdrawn production of polysaccharide vaccines has resulted in reduced country access, particularly for MICs in various regions. For example, Sanofi Pasteur, manufacturer of Menomune, declared in 2017 that the company is discontinuing the production of the vaccine. With the production of Menomune at hold, there were no polysaccharide vaccines approved for use in the United States

Meningococcal Vaccines Market Segmentation

By treatment, the market is segmented into Meningococcal Conjugate Vaccine, Polysaccharide, Subcapsular Vaccine.

Meningococcal A conjugate vaccine is significantly used in mass campaigns across affected regions like Africa. Since 2010, the vaccine has significantly decreased meningococcal disease incidence in the region. However, the demand for meningococcal A conjugate in the country remains uncertain given that national immunization program adoptions are based on the timing of Gavi funding decisions, the country’s readiness, and competing for vaccine introduction priorities.

In the polysaccharide segment, products such as MenACWY vaccines are in high demand. MenACWY vaccine is the most desirable combination, given its broader serotype coverage. MenACWY specifically has nine products that are available across polysaccharide and conjugate product segments, but conjugate products are suggested for use in routine immunization activities.

Moreover, the demand and supply of Subcap MenB vaccines is restricted to HICs and influenced by their acceptance into NIPs. Improved uptake of MenB vaccines is expected in the coming years but will likely be moderate and limited to high-income markets given the high price and competing interest of introducing MenACWY conjugate.

By end-user, the market is segmented into Hospital & Clinical, Research Laboratories, and Academic Institutes

Hospitals and clinics control the global market for meningococcal vaccines. The high growth of hospitals and clinics segment is attributed to the increasing application of vaccines in these healthcare facilities in conjunction with the growing prevalence and incidence of the meningococcal disease.

Moreover, research laboratories and academic institutes take up the second-largest share due to the boost in research and development in the market.

By region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

In the global market, China is expected to have the largest market share, which accounts for approximately 35% of the global demand. This is primarily due to polysaccharide products, which currently comprise 84% of China’s demand. Chinese suppliers presently focus only on meeting the demand of the domestic market, but some of the manufacturers have indicated interest in the global market as well. The dynamic product pipeline with several multivalent conjugate products in development may trigger changes in the future supply mix of the Chinese market. Moreover, in China, non-routine use (excluding campaigns) accounts for an estimated 9 million doses in 2019, which may help to sustain the huge market share in the forecast period.

UNICEF foresees all 26 African countries in the meningitis belt, which have completed mass campaigns in 2016. In 2015, seven countries in the region were introduced with meningococcal A conjugate vaccine through their mass campaigns and targeted a population of 233 million. Further, during 2016-2018, UNICEF introduced meningococcal A conjugate vaccine in 26 countries. Ghana was the first country to be introduced with the vaccine into its RI schedule in 2016. Also, four other countries including Mali, Niger, Nigeria, and Sudan introduced the vaccine into RI programs in 2016.

Key Developments in the Global Meningococcal Vaccines Market

• In 2018, Pfizer granted FDA Breakthrough Therapy designation for Trumenba (Meningococcal Group B Vaccine). This vaccine plays a major role in the prevention of invasive meningococcal B disease in children aged 1 to 9 years

• In 2018, GSK’s meningitis B vaccine Bexsero received Breakthrough Therapy designation from the US FDA for prevention of Invasive Meningococcal Disease for children 2-10 years of age

• In 2015, Novartis Bexsero vaccine was approved by the FDA for the prevention of meningitis B. This vaccine is used as active immunization to prevent invasive meningococcal disease caused by serogroup B

Key Players

• Baxter international
• Pfizer Inc.
• Sanofi S.A.
• Novartis Pharmaceuticals Inc.
• JN-International Medical Corporation
• Serum Institute of India Ltd.
• GlaxoSmithKline
• BIO-MED
• Others

Browse more Details of the Report @ https://www.marketresearchfuture.com/reports/meningococcal-vaccines-market-8622

Cell Counting Market 2019 – Leading Manufactures, Regions, Drivers, Analysis And Forecasts Till 2025

Market Highlights

According to MRFR analysis, Cell Counting Market is expected to register a CAGR of 5.8% during the forecast period of 2019 to 2025 and was valued at USD 8.47 Billion in 2018.

Cell counting is important for research and serves as one of the major steps in the majority of experiments. It is effectively utilized for maintaining cell cultures. Moreover, another important application of cell counting can be seen in the diagnosis of chronic diseases like cancer. For instance, an increase in the number of white blood cells (WBC) may indicate the possibility of cancerous growth in the body. Thus, cell counting is important for microbiology, hematology and other medical specialties.

The growth of the global cell counting market is determined by numerous factors such as increasing R&D expenditure, rising prevalence of cancer, and product launches. However, the high cost of devices and product recalls are projected to restrain the growth of the market during the forecast period.

The Global Cell Counting Market is currently dominated by several market players. The key players are involved in product launches, expansion, and strategic collaborations to strengthen their market positions. Recently in April 2019, the Nexcelom Bioscience LLC launched Cellaca MX automated cell counter.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is anticipated to hold the largest market share owing to the increase in the incidence of cancer and the presence of well-established pharmaceutical and biotechnology industry. The cell counting market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada.

The European cell counting market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The cell counting market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the presence of a large patient pool and expansion of healthcare facilities, the market in Asia-Pacific is expected to be the fastest-growing. The cell counting market in the Middle East & Africa has been divided into the Middle East and Africa.

Segmentation

The Global Cell Counting Market has been segmented based on product, application, and end-user.

The market, based on type, has been divided into consumables and instruments. The consumable segment is likely to hold maximum market share in the global cell counting market. This due to the repeated purchase of the consumable compared with instrument products.

The global cell counting market based on application has been segregated into research application, clinical & diagnostic application, and others. The research application segment is anticipated to hold the largest share in the market due to the rising funding for stem cell research.

The end-user segments of the market are pharmaceutical and biotechnology companies, hospitals, research institutes, and others. The pharmaceutical and biotechnology companies’ segment is expected to hold the largest share of the market, as these are used cell counting products in research and development of new drugs and therapies.

Key Players

Some of the Key Players in the Global Cell Counting Market are Thermo Fisher Scientific (US), Merck KGaA (Germany), Danaher Corporation (US), Bio-Rad Laboratories, Inc. (US), Logos Biosystems, Inc. (South Korea), Olympus Corporation (Japan), Agilent Technologies, Inc. (US), PerkinElmer, Inc. (US), Sysmex Corporation (Japan), Abbott Laboratories (US), and others.

Browse More Report Details @ https://www.marketresearchfuture.com/reports/cell-counting-market-8600

International Medical Drones Market 2019 Estimation And Forecasts Up To 2025

Market Forecast

Medical Drones’ Market is expected to worth USD 398 Million by 2025 and is anticipated to register a CAGR of 24.4% during the forecast period (2019 to2025).

Market Synopsis

Medical drones help in the transport of medical supplies such as vaccines, medications, and medical aids. These drones are deployed in remote or inaccessible areas for the rapid & secure distribution of medical supplies and the war-torn regions from medical facilities. Rising public acceptance of medical drone is also driving the growth in medical drones market demand.

Medical Drones Market, In recent years, has been seeking the attention of healthcare providers and governments to offer better healthcare services to remote locations. These drones help in on-time delivery of vaccines, medication, blood, and supplies to the origin and thereby reduce the outbreaks of life-threatening infectious diseases.

How can this technology help in improving safety and care delivery?

• Bedside medication delivery
• Effective treatment from the distance
• Easy reach to an isolated place
• Pre-treatment facility till the time emergency service arrives at takeover

Most of the key players in the market are focusing on developing medical drones to deliver medical supplies to far distances. For instance, in 2016, a Nevada based start-up Flirtey delivered medical test materials and supplies to and from an offshore vessel. This was the first successful ship to shore delivery in the U.S.

Market Influencer

Increasing investments by key players in R&D is the key factor driving the growth of the Global Medical Drones’ Market.

Market Drivers

• Rising participation of Governments in various countries: Active involvement of local governments towards the deployment of drone service to remote and isolated areas is boosting the growth of the market. For instance, in 2018, the government of Ghana has signed an agreement with Zipline (US) for the deployment of drones throughout the country to provide medical supplies to untapped regions

• Increasing application of drone for the supply of medical products such as blood, pharmaceuticals/drugs, and vaccines are anticipated to propel the market growth during the forecast period

• Technological advancements to improving the accuracy of medical drones during emergency cases backed by R&D activities by key players

Market Restraints

• Medical drones. Medical drones are not allowed to fly without the permission of the government. Thus, product approval laws are expected to restrict the growth of the medical drone’s market during the forecast period.

Segmentation

By Application

• Blood Transfer: Rising incidence of severe bleeding deaths is boosting the demand for medical drones. The blood transfer segment is anticipated to show a growth rate of ~24% during the analysis period. According to the MRFR analysis, each year, around 60,000 Americans die from blood loss or hemorrhaging. Moreover, around 2 million people die across the globe.

• Pharmaceutical/Drugs Transfer: The increasing focus of key medical drones vendors towards the development of drones for medication delivery is boosting the growth of this segment.

• Vaccines Transfer: This segment is mainly on the drones that are associated with the delivery of the vaccine.

By End-User

• Emergency Medical Services: This segment held the largest market share in 2018, owing to continues advancements in technology. For instance, in 2019, an automated drone’s delivery company Zipline (US), has planned for the expansion of a medical drone network into Ghana for emergency services.

• Blood Banks: Owing to poor road conditions, transporting blood in underdeveloped countries is a huge task. Medical drones carry blood, plasma, and platelets from blood banks to remote hospitals and clinics.

By Region

• Americas: The Americas held the largest regional market in 2018, owing to rising technology advancement. Moreover, the governments in this region are also promoting the acceptance of medical drones, as a result, players are aggressively working to develop advanced drones. In October 2019, United Parcel Services (US) received an authority from the Federal Aviation Administration to deliver medical packages at hospitals across the country.

• Europe: The European market is expected to be the second-largest market in 2025. The market growth in this region can be attributed to government funding and support to the healthcare sector, coupled with increasing research and development.

• Asia-Pacific: Asia-Pacific is the fastest-growing region for the medical drones market owing to the improving healthcare infrastructure, rising investments in healthcare, and expansions by market players in the region. Also, countries such as India and China are expected to be the fastest-growing in the region due to the focus of governments towards the adoption of new technologies and faster adoption of best treatment options from developed countries.

• Middle East & Africa: It is projected to account for the least share of the global market due to an underdeveloped healthcare sector.

Key Players

• DJI (China)
• DHL (Germany)
• Embention (Spain)
• Flirtey (US)
• Matternet (US)
• Vayu (US)
• Zipline (US)
• EHang (China)
• TUDelft (Netherlands)

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/medical-drones-market-8596